NCT05775757 SMC Radiation Oncology Breast Cancer Cohort Study
| NCT ID | NCT05775757 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samsung Medical Center |
| Condition | Radiotherapy Side Effect |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2021-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about toxicities and cosmetic outcomes in breast cancer patients treated with hypofractionated radiotherapy. The main question it aims to answer are: * Changes in breast skin * Factors related to breast skin changes * Patient-reported outcomes * Cosmetic outcomes Participants will be assessed by multi-dimensional methods before and after radiotherapy: * Photographs * Fibrometer * Questionnaires (BREAST-Q) * CTCAE version 4.03 evaluated by treating physicians
Eligibility Criteria
Inclusion Criteria: * Breast cancer treated with curative surgery Exclusion Criteria: * History of thoracic radiation therapy
Contact & Investigator
Haeyoung Kim, MD, PhD
PRINCIPAL INVESTIGATOR
Samsung Medical Center
Frequently Asked Questions
Who can join the NCT05775757 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 85 Years, studying Radiotherapy Side Effect. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05775757 currently recruiting?
Yes, NCT05775757 is actively recruiting participants. Contact the research team at haeyoung0131.kim@samsung.com for enrollment information.
Where is the NCT05775757 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT05775757 clinical trial?
NCT05775757 is sponsored by Samsung Medical Center. The principal investigator is Haeyoung Kim, MD, PhD at Samsung Medical Center. The trial plans to enroll 500 participants.